The milkweed bush Gomphocarpus fruticosus R.Br. found in Australia contains the steroidal glycoside (+)-gomphoside, its derivatives (-)-3ꞌ-dehydrogomphoside and (+)-3ꞌ-epi-gomphoside, as well as other glycoside compounds. The key structural features of these unique herbal agents are bislinked steroid to sugar linkages. (+)-Gomphoside is an extremely potent cardenolide and highly effective Hypoxia-Inducible Factor (HIF)-1 inhibitor. In addition, (+)-gomphoside exhibits strong cytotoxicity on human breast cancer cell lines.
The milkweed bush Gomphocarpus fruticosus R.Br. was firstly collected and described at the beginning of the 19 th century in Australia by the Scottish physician and renowned botanist Robert Brown [1a] . The plant belongs to the Asclepiadaceae and is also widely known as Asclepias fruticosa L. (Figure 1 ). In 1956 Watson et al. isolated a crystalline mixture of two substances from the dried whole plant of Gomphocarpus fruticosus R.Br., which they named gomphoside 1 and afroside (15-hydroxygomphoside) 2, respectively [2].
They subsequently described the separation of both compounds and specified the rotations for gomphoside 1 with α +16 (MeOH) [2b, 3] and for afroside 2 with α −20 (pyridine) [4] . Later, two other derivatives of gomphoside, the (-)-3ꞌ-dehydrogomphoside 3a and the (+)-3ꞌ-epi-gomphoside 3b were isolated from the same plant species [5] (Figure 2 ). Cheung and Watson [6] published the structures of (+)-gomphoside 1 and (-)-afroside 2 as well as structures of numerous cardenolide glycosides isolated from Asclepiadaceae plants. The characteristical structural feature of these natural products is the 4,6-dideoxyhexulose sugar, whose C-1ꞌ and C-2ꞌ atoms are bislinked to the 3 and 2 oxygen atoms of the steroid ring system of the aglycone [6] . Due to this acetal and hemiacetal linkage (+)-gomphoside 1 cannot be hydrolyzed by any of the usual methods without decomposition of both the carbohydrate and the aglycone [7] .
Mutlib and Watson studied the metabolism of [ 3 H]-gomphoside 1 in vivo in male Wistar rats, and in vitro using rat liver microsomes. They showed that the aglycone of gomphoside, viz. gomphogenin was the major metabolite [8] . They also investigated the 328 Natural Product Communications Vol. 13 (3) 2018 Cuny pharmacokinetics and tissue distribution and found that shortly after injection (3 min) most of the gomphoside accumulated in the liver (32%) and skeletal muscle (31%). The average elimination half-life of 3.7 h and large volume of distribution (2.3 mL/g body weight) were comparable to commonly used cardiac glycosides [9] . Brown et al. showed that cardiac glycosides with bislinked, i.e. nonrotating, steroid to sugar linkages, such as gomphoside 1, 15-hydroxygomphoside (afroside) 2, 3ꞌ-dehydrogomphoside 3a, and 3ꞌ-epi-gomphoside 3b are ideal tools to study digitalis structureactivity relationships. They determined the relative inotropic potency ratio of gomphosides 1, 2, 3a, and 3b as 23 : 1.6 : 2.5 : 0.2. They also identified (+)-gomphoside 1 as an extremely potent cardiac glycoside that is approximately 10 times more potent than digoxin, as shown experimentally in vivo on guinea pig left atria. [10] . Studies by Watson et al. disclosed that the axial 3ꞌ-OH group arrangement in the sugar moiety is the main conformational factor responsible for this pronounced inotropic activity of (+)-gomphoside 1 [11] . Further investigations by Repke and Watson revealed that this high affinity towards Na + /K + -ATPase from guinea-pig heart is considerably reduced by mono-and bisacetylation of the sugar portion [12] . In 2016 a Chinese group published that (+)-gomphoside 1, isolated from Calotropis gigantea, exhibited a three-fold more potent HIF-1 inhibitory effect than digoxin, a well-studied HIF-1 inhibitor. In addition, 1 exhibited strong cytotoxic effects on the human breast cancer cell line MCF-7 [13] .
Lichtenthaler et al. developed a practical method for the bisacetalic annulation of 2-ketosugars to glycol [14], 1,2-cycohexane diols [15] , cholestanediol [16] , and gomphogenin, which led to the successful synthesis of the natural products (+)-gomphoside 1, (-)-3ꞌ-dehydrogomphoside 3a and (+)-3ꞌ-epi-gomphoside 3b [17] . Here, the syntheses of analogues thereof are described. The structural changes of the analogues were made by starting from natural cholesterol. The steroidal D ring was modified by replacing the exocyclic butenolide moiety with a C 8 H 17 -alkyl chain, and removing the hydroxyl group at carbon-14, as well as changing the configuration at this position. The described analogues of 1 given here are possibly suitable candidates for the development of new inhibitors in cancer therapy.
Syntheses
The reaction of (+)-(2α,3β,5α)-2,3-cholestanediol 6 [18] with D-glucose-derived ulosyl bromide 4 [19] in dichloromethane and in the presence of silver carbonate as promoter yielded smoothly a 1:3-mixture ( 1 H NMR) of the two, ring-linked steroidal regioisomers 7a and 7b within 4 h under reflux temperature. The two hydroxyl groups (2-OH, 3-OH) in (+)-(2α,3β,5α)-2,3-cholestanediol 6 possess different reactivity, thus resulting in bent up and bent down molecular geometry of the products. After chromatographic separation, the two glycosides were obtained in 16% (7a) and 64% (7b) yield, respectively. The same reaction with the 6-deoxyulosyl bromide 5 [14a, 19] gave the two appropriate regioisomeric compounds in 25% (8a) and 57% (8b) yield, respectively (Scheme 1).
Converting the carbohydrate portion of the synthesized bent up (7a, 8a) and bent down steroidal glycosides (7b, 8b) to their analogues, as realized in the natural products, proved to be another challenge (Scheme 2 and Figure 3 ). This synthesis procedure involves the removal of the benzoyl oxy group at C-4ꞌ, generation of a carbonyl function at C-3ꞌ, and stereoselective reduction of the latter. The methodology for this reaction sequence was firstly developed by Lichtenthaler et 
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Scheme 2: Synthesis of analogues with bent up molecular geometry by base-induced transformation of the steroidal glycosides 7a and 8a into the 3ꞌ-dehydrogomphoside analogues 9a, 10a, and 11a followed by reduction to the gomphoside analogues 12a and 13a.
Reaction of the four steroidal glycosides 7a, 7b, 8a, and 8b with tetrabutylammonium acetate in anhydrous dichloromethane gave the corresponding benzoylated 3ꞌ-dehydrogomphoside analogues 9a, 9b, 10a, and 10b in good yields. The same reactions of 8a and 8b in a mixture of acetonitrile/water led directly to the unblocked 3ꞌ-dehydrogomphoside analogues 11a and 11b in 90% yield (Scheme 2 and Figure 3 ).
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The C-3'-carbonyl group of the 3ꞌ-dehydrogomphoside analogues 11a and 11b were successfully reduced to an axial as well as an equatorial OH-group by either hydrogenation on a rhodium catalyst or by hydride reduction with sodium borohydride in methanol. The respective gomphoside analogues 12a, 12b and the 3ꞌ-epigomphoside derivatives 13a, 13b were obtained in good yields and high stereoselectivities (Scheme 2 and Figure 3 An overreduction of the analogues 11a and 11b with sodium borohydride in methanol caused by its hemiacetal ring-opened form, as described by Cheung et al. for natural 3ꞌ-dehydrogomphoside 3a [20] , was prevented by exclusion of moisture and short reaction times.
A likely mechanism [14b] for the transformation of the steroidal glycosides 7, 8 (a-and b-series) to the 3ꞌ-dehydrogomphoside analogues 9, 10, and 11 by base-induced oxidation (C-3ꞌ) and deoxygenation (C-4ꞌ) is shown in Scheme 3. Elimination of one molecule of benzoic acid of the keto form I, which is in equilibrium with the cyclized acetals 7, 8, using the relative weak base tetrabutylammonium acetate affords the enolone II, which cyclizes to III. A benzoyl group migration yields the benzoates 9, 10, whilst saponification and elimination of a second molecule of benzoic acid occurs in the presence of water (11). The relative high yield (90%) obtained by the latter reaction shows that the enolester hydrolysis is the preferred reaction, whereas the benzoyl group migration is unfavorable under those conditions.
Scheme 3: Mechanism of the base-induced oxidation (C-3ꞌ) and deoxygenation (C-4ꞌ) of the steroidal glycosides 7, 8 (a-and b-series) into the 3ꞌ-dehydrogomphoside analogues 9, 10 and 11 by gradual elimination of benzoic acid.
Structural Elucidation
The 1 H and 13 C NMR data of the synthesized compounds are listed in Table 1 and 2 as well as in the Supporting Information. Figure 4 ) confirmed the configuration of the starting compounds 7a, 7b, 8a and 8b at C-1ꞌ and C-2ꞌ which result from bisacetalic annulation of the 2-ketosugars 4a, 4b, 5a and 5b with the steroidal diol 6. The sharp singlet resonance of the anomeric proton 1ꞌ-H shows strong NOE interactions with the axially oriented pyranose protons 3ꞌ-H and 5ꞌ-H. A weaker effect between 1ꞌ-H and the proton of the directly adjacent equatorial 2ꞌ-OH group was also observed. These results were in accordance with previous studies [14, 15] . The assignment of the steroidal bridge head atoms, 2-H and 3-H as well as C-2 and C-3 of 7a, 7b, 8a, and 8b were established on the basis of NOE measurements and HMBC spectra ( Figure 5) . Figure 5: NOE effects of the steroidal glycosides 7a, 7b, 8a, and 8b in the steroid portion as well as HMBC interactions C-2ꞌ → 2-H and 1ꞌ-H → C-3 (red) (7a, 8a) and C-2ꞌ → 3-H and 1ꞌ-H → C-2 (blue) (7b, 8b) for the successful assignment of the chemical shifts of 2-H and 3-H as well as for C-2 and C-3.
A. Stereochemistry in the sugar and steroid moiety of 7 and 8 NOE interactions (blue arrows in
Thus, the NOE effects between 2-H and 19-H 3 are obvious for the chemical shift of 2-H and as a consequence for 3-H, C-2 and C-3, too. The HMBC spectra confirmed these results. Two aspects were essential in these examinations: firstly, the observed interactions between C-2ꞌ → 2-H and 1ꞌ-H → C-3 (7a, 8a) ( Figure 5 , marked in red) and secondly the interactions between C-2ꞌ → 3-H and 1ꞌ-H → C-2 (7b, 8b) ( Figure 5 , marked in blue).
B. Bent up and bent down geometry of 7, 8, 14, and 15
Determining the regiochemistry of the steroidal glycosides 7a, 7b, 8a and 8b with regard to a bent up (a-series) or bent down (b-series) annulation of steroid and sugar moiety was challenging, because suitable protons for NOE measurements were lacking. For that reasons the four compounds were deoxygenated at position C-2ꞌ of their sugar moiety. This was performed with an excess of triethylsilane/boron trifluoride etherate in a mixture of acetonitrile/1,2-dichloroethane. The resulting ethers 14a, 14b, 15a, and 15b were obtained smoothly and in good yields (Scheme 4).
The unequivocal differentiation between bent up and bent down geometry of the above synthesized ether is also shown in Scheme 4. Thus, the compound pair 14a/15a had the characteristical NOE effects 2ꞌ-H  2-H and 2-H  19-Me whilst the isomeric 14b/15b had those of 2ꞌ-H  3-H and 2H  19-Me (red arrows). Consequently, 14a/15a possess bent up and 14b/15b bent down molecular geometry, respectively. Their stereochemistry in the sugar portion was revealed by the small e,a-coupling constants of 1ꞌ-H/2ꞌ-H (0.4 -1.1 Hz) and of 2ꞌ-H/3ꞌ-H (3.2 -3.6 Hz) ( Scheme 4: Deoxygenation at C-2ꞌ of the glycosides 7a, 8a, 7b, and 8b and NOE measurements of the resulting ethers 14a, 15a, 14b, and 15b.
The additional observed NOE interactions of 2ꞌ-H  1ꞌ-H and of 2ꞌ-H  3ꞌ-H (blue arrows) are in accordance. These findings substantiate that the configuration at C-2ꞌ was maintained during the deoxygenation reaction [s. also 15].
C. C-3ꞌ-constitution and configuration of 9-13
The formation of the (-)-3ꞌ-dehydrogomphoside analogues 9a, 9b, 10a, 10b, 11a, and 11b with a C-3ꞌ carbonyl group and a 4ꞌ-CH 2 function in the sugar portion was validated by their 13 C NMR resonance above δ = 195 ppm for C-3ꞌ and the existence of two 1 H NMR double doublets for 4ꞌ-H a and 4ꞌ-H e (Table 1 and Table 2 ).
The configuration of the newly formed alcoholic stereocenter at carbon-3ꞌ of the following final reduction products was confirmed by their respective 1 H NMR spectra and the presence of a 1 H NMR resonance at C-3ꞌ (formerly a carbonyl group): the gomphoside analogues 12a and 12b (equatorial 3ꞌ-H, axial 3ꞌ-OH) and the 3ꞌ-epigomphoside analogues 13a and 13b (axial 3ꞌ-H, equatorial 3ꞌ-OH). In the case of 12a and 12b these were double doublets at δ = 3.73 ppm exhibiting small coupling constants of J 3'e,4'a = J 3'e,4'e = 2.8 Hz (12a) and J 3'e,4'a = J 3'e,4'e = 2.7 Hz (12b). For 13a and 13b these were multiplets at δ = 3.61 and 3.62 ppm ( Table 1) . As expected the 13 C NMR C=O resonances of the starting products 11a and 11b above δ = 200 ppm had disappeared and new signals for C-3ꞌ were observed at δ = 70.80 (12a) and 73.47 ppm (13a), respectively ( Table 2 ). The observed sharp 1 H NMR singlet resonances for the anomeric protons 1ꞌ-H 12a (δ = 4.78 ppm), 12b (4.79), 13a (4.60) and 13b (4.60) and the absence of a 2ꞌ-H resonance clearly confirm that no overreduction had occurred. (Table 1 ). These findings were also confirmed by the existence of a quaternary C-2ꞌ resonance (91.17 ppm) in the 13 C NMR spectrum of 13a (Table 2 ). 
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Conclusions
The milkweed bush Gomphocarpus fruticosus R.Br. contains (+)-gomphoside 1, (-)-3ꞌ-dehydrogomphoside 3a, (+)-3ꞌ-epigomphoside 3b, and other glycosides. Key structural features of these unique herbal agents are the non-rotating steroid to sugar linkages. (+)-Gomphoside 1 is an extremely potent cardiac glycoside and active HIF-1 inhibitor. In addition, it exhibits strong cytotoxic effects on a human breast cancer cell line. Currently uncharacterized compounds with similar structure, but modified steroidal D rings are potentially suitable as candidates for the development of new inhibitors in cancer therapy.
The syntheses of gomphoside analogues described here started from the well-known (+)-(2α,3β,5α)-2,3-cholestanediol 6 and the ulosyl bromides 4 or 5, and yielded in each case two ring-linked steroidal regioisomers with bent up (7a, 8a) and bent down ring anellation (7b, 8b). Chromatographic separation and treatment with tetrabutylammonium acetate in the presence of anhydrous dichloromethane gave the four benzoylated 3ꞌ-dehydrogomphoside analogues 9a, 9b, 10a and 10b. The same reaction in a mixture of acetonitrile/water led directly to the unblocked 3ꞌ-dehydrogomphoside derivatives 11a and 11b. The respective derivatives of gomphoside 12a and 12b and of 3ꞌ-epi-gomphoside 13a and 13b were received by either hydrogenation on a rhodium catalyst or by hydride reduction with sodium borohydride in methanol. The determination of the regiochemistry of the glycosides 7a, 7b, 8a and 8b and thus also for the subsequent products was performed by deoxygenation at C-2ꞌ (→ 14a, 14b, 15a, 15b ) and NOE measurements.
1 H and 13 C NMR spectroscopic analysis substantiate the structures of all products. The synthesized gomphoside analogues 11, 12, and 13 are new and unique, and their altered chemical properties make them promising lead structures for pharmacological evaluation. Although these compounds are probably less promising candidates for prospective new cardenolides because they lack a steroidal butenolide ring, which is the main structural element responsible for inotropic activity, their unique structures suggest they have other interesting pharmacological properties. Bioactivity and cytotoxicity tests for cancer research would be the logical first steps towards uncovering the pharmacological and medical potential of these compounds, in particular with respect to cancer treatment.
Experimental
General: TLC was performed on POLYGRAM ® SILG/UV 254 (Macherey Nagel & Co.). Chromatographic separations were carried out on Merck silica gel 60 (15-40 μm). Melting points were determined on a Bock-Monoskop VS or on a Büchi SMP-20 and are uncorrected. Specific optical rotations were determined on a PerkinElmer Polarimeter 241 in 1-dm cuvettes at a wavelength of 589 nm. NMR spectra were measured on Bruker WM 300, AC 300, DRX 500 or Avance III HD 700 MHz spectrometers at 303 K using TMS as internal reference or by calibration with the signal of the solvent CDCl 3 (δ CHCl3 = 7.26 ppm, δ CDCl3 = 77.16 ppm) [21] . The multiplicities of the signals are abbreviated as s for singlet, d for doublet, t for triplet, q for quartet, m for multiplet, br for broad. Mass spectra were run on a MAT 311 A or MAT 212 mass spectrometer (Varian). Elemental analyses were performed on a Perkin Elmer 240 Elementar Analyser. Table 2 . 13 C NMR (176 MHz, CDCl 3 , 300K): Supporting Information.
Steroidal glycosides 7a and 7b by reaction of (+)-(2,3,5)-cholestane-2,3-diol 6 with ulosyl bromide 4: Cholestane-2,3-diol 6 (405 mg, 1 mmol) [18a] was dissolved by gentle heating in anhydrous CH 2 Cl 2 (50 mL) followed by the addition of silver carbonate (276 mg, 1 mmol) and freshly dried molecular sieve 4 Å (2 g). After the mixture was stirred for 15 min at room temperature and under the absence of light ulosyl bromide 4 (553 mg, 1 mmol) [19] was added in one portion and the mixture heated at reflux (4 h) under the exclusion of moisture. The silver salts were removed by filtration through a pad of kieselgur and the filter rewashed with CH 2 Cl 2 . The combined filtrates, an approximate 3:1-mixture of 7b and 7a ( 1 H NMR) together with unreacted cholestane-2,3-diol 6 (TLC R f 0.57, 0.39 and 0, toluene/ethyl acetate 8:1) were evaporated under vacuum. To remove the polar 6, the remaining crystalline residue was dissolved in a small quantity of dioxane followed by flash chromatography on silica gel (column 30 x 2.5 cm, benzene/ethyl acetate 4:1). The combined fractions consisting of the glycosides 7a and 7b were evaporated under vacuum and separated by fractional crystallization. This was achieved by boiling the remaining crystalline residue in acetone (30 mL) until complete dissolution had occurred. Leaving of the solution overnight at -20 °C gave 563 mg (64 %) of 7b as colorless crystals with R f 0. Steroidal glycosides 8a and 8b by reaction of (+)-(2,3,5)-cholestan-2,3-diol 6 with 6-deoxyulosyl bromide 5: A mixture of 6 (0.81 g, 2 mmol) and silver carbonate (2,76 g, 10 mmol) were stirred during 5 min in anhydrous CH 2 Cl 2 (100 mL) as described for the synthesis of the steroidal glycosides 7a and 7b. Afterwards a solution of freshly prepared 6-deoxyulosyl bromide 5 (3.76 g, 8 mmol) [19] in anhydrous CH 2 Cl 2 (10 mL) was added drop-wise and the mixture stirred for another 16 h at room temperature and under the absence of light. The silver salts were removed by filtration through a pad of kieselgur and the filter rewashed with CH 2 Cl 2 . The combined filtrates were evaporated under vacuum whereby unreacted cholestane-2,3-diol 6 precipitated and could be removed by filtration (0. Benzoate 9a by reaction of 7a with tetra n-butylammonium acetate in dichloromethane: To a solution of 7a (88 mg, 0.10 mmol) in anhydrous CH 2 Cl 2 (7 mL) tetra n-butylammonium acetate (91 mg, 0.30 mmol) was added and the mixture stirred for 15 h at room temperature. Afterwards the reaction mixture was diluted with CH 2 Cl 2 (50 mL), washed with water (3 x 25 mL), dried (Na 2 SO 4 ) and evaporated in vacuum Purification of the residue by flash chromatography (20 x 2 cm, toluene/ethyl acetate 40:1) yielded 38 mg (50 %) of chromatographically pure 9a as a syrup with R f 0.59, (toluene/ethyl acetate 8:1) and α -17.1 (c = 0.7, CHCl 3 Benzoate 9b by reaction of 7b with tetra n-butylammonium acetate in dichloromethane: A solution of 7b (132 mg, 0.15 mmol) in anhydrous CH 2 Cl 2 (10 mL) was reacted with tetra nbutylammonium acetate (136 mg, 0.45 mmol) as described for the synthesis of 9a. A chromatographically purification was not necessary since after evaporation in vacuum the remaining syrup crystalized by the addition of acetone (10 mL 6'-Deoxybenzoate 10a by reaction of 8a with tetra nbutylammonium acetate in dichloromethane: As described for the preparation of 9a, a solution of 8a (76 mg, 0.10 mmol) in anhydrous CH 2 Cl 2 (10 mL) was reacted with tetra n-butylammonium acetate (90 mg, 0.30 mmol) for 18 h at room temperature. After work-up as above and flash chromatography (2 x 1 cm, toluene/ethyl acetate 8:1) 62 mg (98 %) of 10a were obtained as a syrup with R f 0. Table 1 . 13 C NMR (125 MHz, CDCl 3 ): Table 2. 3'-Dehydrogomphoside analogue 11a by reaction of 8a with tetra n-butylammonium acetate in acetonitrile / water: To a solution of 8a (338 mg, 0.45 mmol) in acetonitrile (100 mL) tetra nbutylammonium acetate (407 mg, 1.35 mmol) and one drop of water were added. The mixture was stirred at room temperature for 24 h, subsequently diluted with CH 2 Cl 2 (100 mL), washed successively with saturated NaHCO 3 -solution (2 x 50 mL) and water (50 mL) and dried (Na 2 SO 4 Table 1 . 13 C NMR (125 MHz, CDCl 3 ): Table 2. 3'-Dehydrogomphoside analogue 11b by reaction of 8b with tetra n-butylammonium acetate in acetonitrile / water: A solution of 8b (757 mg, 1.00 mmol) and tetra n-butylammonium acetate (905 mg, 3.00 mmol) in acetonitrile (180 mL) which contained two drops of water was reacted as described for the synthesis of 11a to give 470 mg (89 %) of 11b as a syrup with R f 0.45 (toluene/ethyl acetate 8:1). An analytically pure and crystalline sample was obtained by flash chromatography ( Table 1 .
